SNAI1 and breast neoplasm: To determine the clinical relevance of our findings, we performed immunohistochemical (IHC) staining using a tissue microarray (TMA) containing 126 human breast tumor samples with an antibody against MORC2, O-GlcNAc, OGT, GFAT, SNAIL, or CTGF.